Cryoport, Inc. (CYRX)
19.89
-0.28
(-1.39%)
USD |
NASDAQ |
Nov 19, 13:19
Cryoport Debt to Equity Ratio : 0.4788 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.4788 |
| June 30, 2026 | 0.4728 |
| March 31, 2026 | 0.4656 |
| December 31, 2025 | 0.459 |
| September 30, 2025 | 0.4498 |
| June 30, 2025 | 0.4434 |
| March 31, 2025 | 0.6085 |
| December 31, 2024 | 0.6035 |
| September 30, 2024 | 0.5575 |
| June 30, 2024 | 1.011 |
| March 31, 2024 | 0.8788 |
| December 31, 2023 | 0.8507 |
| September 30, 2023 | 0.7696 |
| June 30, 2023 | 0.8102 |
| March 31, 2023 | 0.785 |
| December 31, 2022 | 0.7842 |
| September 30, 2022 | 0.7806 |
| June 30, 2022 | 0.7576 |
| March 31, 2022 | 0.6971 |
| December 31, 2021 | 0.6654 |
| September 30, 2021 | 0.2097 |
| June 30, 2021 | 0.2084 |
| March 31, 2021 | 0.2035 |
| December 31, 2020 | 0.3421 |
| September 30, 2020 | 0.9982 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.9267 |
| March 31, 2020 | 0.0519 |
| December 31, 2019 | 0.038 |
| September 30, 2019 | 0.1777 |
| June 30, 2019 | 0.1768 |
| March 31, 2019 | 0.431 |
| December 31, 2018 | 0.3831 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.0345 |
| December 31, 2016 | 0.1128 |
| September 30, 2016 | 0.20 |
| June 30, 2016 | 0.1698 |
| March 31, 2016 | |
| March 31, 2015 | -3.685 |
| December 31, 2014 | -1.479 |
| September 30, 2014 | -0.9655 |
| June 30, 2014 | -1.268 |
| March 31, 2014 | -1.293 |
| December 31, 2013 | -1.260 |
| September 30, 2013 | -1.044 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IQVIA Holdings, Inc. | 2.450 |
| Protect Pharmaceutical Corp. | -0.1837 |
| Champions Oncology, Inc. | 2.818 |
| Medpace Holdings, Inc. | 0.2931 |
| Charles River Laboratories International, Inc. | 0.8838 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 750.94M |
| Total Liabilities (Quarterly) | 267.43M |
| Shareholders Equity (Quarterly) | 483.51M |
| Current Ratio | 2.037 |
| Net Debt Paydown Yield | -0.07% |